KIMS Hospitals Financial Highlights and ESG Initiatives slide image

KIMS Hospitals Financial Highlights and ESG Initiatives

KIMS Financial & Operational Highlights - 2/2 FINANCIAL HIGHLIGHTS Q3 FY 23 Consolidated • Consolidated Revenue from operations grew by 42.8% YoY basis to Rs. 5,622 mn. • Consolidated Adjusted EBITDA (Excluding Other Income, INDAS adjustments, and one-off items) grew by 14% on a YoY basis to Rs. 1,470 mn. • Consolidated Adjusted EBITDA Margin stands at 26.2%; Ex Nagpur stands at 27.2% (an improvement of 0.1% QoQ). • Recent acquisitions i.e. Sunshine & Nagpur hospital, have shown sequential improvement (ex one-off items) in the EBITDA margin. For Q3 FY 23, Sunshine EBITDA stands at 21.9%, Nagpur EBITDA stands at 11.1%. • During the quarter, the company acquired an additional stake in three of its subsidiaries: 1.92% in Sunshine hospital, 4.07% in Kondapur hospital and 7.79% in Srikakulam Hospitals. Going forward, we aim to acquire further stake in these units. • Company has disposed one of its step-down subsidiaries "Suryateja Healthcare Private Limited” (Sunshine hospital Karimnagar) w.e.f. 1st December' 2022. OPERATIONAL HIGHLIGHTS Q3 FY 23 Consolidated • The new Unit for Sunshine Secunderabad Hospital is in its final stages of completion, and we aim to shift to this new state- of-art facility by FY 24. • Projects undertaken at Nashik (Greenfield project) and Bangalore (Semi Brownfield) are progressing well and are expected to be operational by FY 25. • Vizag Gastro unit is ready and will be operational by FY 24. • We rolled out applications that automate operational workflows, including Financial Counselling, Relationship Management, and Queue Management, among others, for greater operational efficiencies. • ARPP and ARPOB have shown improvements at the group level, though IP volume has declined due to the festive season. Private & Confidential 15
View entire presentation